Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: ...
For these individuals, alternative treatment options, including Radiofrequency (RF) ablation therapy, offer a promising solution. NeuroOne’s OneRF ® ablation system, is the first and only FDA 510 ...
NeuroOne Medical Technologies Corporation EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical ...
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving ...
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and ...
(RTTNews) - NeuroOne Medical Technologies Corporation (NMTC), on Tuesday that CEO Dave Rosa was featured on Today's Marketplace or TMP, discussing the latest advancements in epilepsy treatment ...
NeuroOne Medical Technologies Corporation announced that CEO Dave Rosa participated in an interview on Today’s Marketplace, discussing advancements in epilepsy treatment alongside Dr. Jessica ...
(MENAFN- GlobeNewsWire - Nasdaq) EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the ...
NeuroOne announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback